| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 18 |
| 1 | LAMIVUDINE | 17 |
| 2 | LAMIVUDINE ORAL | 17 |
| 3 | ABACAVIR SULFATE | 15 |
| 4 | DARUNAVIR | 15 |
| 5 | DARUNAVIR 600 MG | 14 |
| 6 | DARUNAVIR 800 MG | 14 |
| 7 | ABACAVIR | 11 |
| 8 | AZITHROMYCIN DIHYDRATE | 10 |
| 9 | FLUCONAZOLE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARUNAVIR 600 MG | 14 | 0.0023 |
| 1 | RALTEGRAVIR | 10 | 0.0019 |
| 2 | ABACAVIR SULFATE | 15 | 0.0015 |
| 3 | CEFOTAXIME INJECTION | 6 | 0.0014 |
| 4 | ETHAMBUTOL HYDROCHLORIDE | 3 | 0.0011 |
| 5 | DARUNAVIR | 15 | 0.0010 |
| 6 | CLINDAMYCIN PHOSPHATE TOPICAL | 3 | 0.0008 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 7 | 0.0008 |
| 8 | DASPONE | 8 | 0.0008 |
| 9 | DAPSONE GEL, 5% | 8 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sulfone [EPC] | 8 | 0.0007 |
| 1 | Protease Inhibitor [EPC] | 19 | 0.0004 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 24 | 0.0004 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 17 | 0.0003 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0003 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 7 | 0.0003 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0003 |
| 8 | Antimycobacterial [EPC] | 5 | 0.0002 |
| 9 | Penem Antibacterial [EPC] | 6 | 0.0002 |